SCHEMBL4142022

SCHEMBL4142022

CCNC(=O)N(C)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPRZ1 P23471 2/20 0.37
EPHX2 P34913 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
PDE2A O00408 1/20 0.34
MCHR1 Q99705 1/20 0.34
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
KCNK2 O95069 2/20 0.33
KCNK10 P57789 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
KIF11 P52732 1/20 0.33
PDK2 Q15119 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PTPN1 P18031 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150851 0.89 PTPRZ1 (0.36) PTPRZ1EPHX2NR1H4PDE2AMCHR1
SCHEMBL4144820 0.86 PTPRZ1 (0.35) PTPRZ1EPHX2NR1H4MCHR1LMNA
SCHEMBL4149965 0.86 ACKR3 (0.38) PTPRZ1EPHX2NR1H4MCHR1MAPK1
SCHEMBL4149940 0.86 PTPRZ1 (0.35) PTPRZ1EPHX2NR1H4PDE2AMCHR1
SCHEMBL4146959 0.85 L3MBTL1 (0.35) PTPRZ1EPHX2NR1H4MCHR1TRPV1
SCHEMBL4150001 0.85 MAPK1 (0.35) PTPRZ1EPHX2NR1H4PDE2AMCHR1
SCHEMBL4149723 0.85 TSHR (0.38) PTPRZ1EPHX2NR1H4PDE2ALMNA
SCHEMBL13774526 0.84 MCHR1 (0.37) PTPRZ1EPHX2NR1H4PDE2AMCHR1
SCHEMBL4141923 0.84 PTGIR (0.36) PTPRZ1PDK2
SCHEMBL4144739 0.84 MAPT (0.46) PTPRZ1EPHX2NR1H4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 PTPRZ1 1175/4885EPHX2 2013/4885NR1H4 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.